Exploring the Etiology of Alzheimer Disease Using Molecular Genetics
JAMA 277:825-831, Lendon,C.L.,et al, 1997
The Clinical Introduction of Genetic Testing for Alzheimer Disease, An Ethical Perspective
JAMA 277:832-836, Post,S.G.,et al, 1997
Clin Features of Early-Onset Alzheimer Disease in Large Kindred with an E280A Presenilin-1 Mutation
JAMA 277:793-799, Lopera,F.,et al, 1997
Weight Loss in People with Alzheimer's Disease:A Prospective Population Based Analysis
BMJ 314:178-179, Cronin-Stubbs,D.,et al, 1997
Drug Treatment of Alzheimer's Disease, Raise Clinical and Ethical Problems
BMJ 314:693-694, Kelley,C.A.,et al, 1997
Apolipoprotein E Genotypes in Primary Progressive Aphasia
Neurol 49:51-55, Mesulam,M.M.,et al, 1997
What Are the Obstacles for an Accurate Clinical Diagnosis of Pick's Disease
Neurol 49:62-69, Litvan,I.,et al, 1997
High-Frequency Unilateral Thalamic Stimulation in the Treatment of Essential and Parkinsonian Tremor
Ann Neurol 42:292-299, Koller,W.,et al, 1997
Donepezil (Aricept) for Alzheimer's Disease
The Medical Letter 39:53-54, , 1997
Increased Risk of Mortality in Alzheimer's Disease Patients with Higher Education
Neurol 49:798-802, Geerlings,M.I.,et al, 1997
Pupil Dilation to Tropicamide is not Specific for Alzheimer Disease
Arch Neurol 54:841-844, Growdon,J.H.,et al, 1997
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
NEJM 336:1216-1222, 12451997., Sano,M.,et al, 1997
Clinical Features and Pharmacologic Treatment of Behavioral Symptoms of Alzheimer's Disease
Neurol 48 (Suppl 6) :S17-S24997., Borson,S.&Raskind,M.A., 1997
Reliability of Wash Univ Road Test:A Performance-Based Assess for Drivers with Dementia of Alzheimer Type
Arch Neurol 54:707-712, Hunt,L.A.,et al, 1997
Midline Cerebral Morphometry Distinguishes Frontotemporal Dementia and Alzheimer's Disease
Neurol 48:978-985, Kaufer,D.I.,et al, 1997
Simulated Car Crashes and Crash Predictors in Drivers with Alzheimer Disease
Arch Neurol 54:545-551, Rizzo,M.,et al, 1997
The Family Caregiver's Role in Alzheimer's Disease
Neurol 48 (Suppl 6) :S25-S29997., Haley,W.E., 1997
Predictors of Time to Institutionalization of Patients with Alzheimer's Disease:The CERAD Experience, Part XVII
Neurol 48:1304-1309, Heyman,A.,et al, 1997
Cognitive Function and The costs of Alzheimer Disease
Arch Neurol 54:687-683, Ernst,R.L.,et al, 1997
Frontotemporal Dementia and Early Alzheimer Disease:Differentiation with Frontal Lobe H-1 MR Spectroscopy
Radiology 203:829-836, Ernst,T.,et al, 1997
Herpes Simplex Virus Type 1 in Brain and Risk of Alzheimer's Disease
Lancet 349:241-244, Itzhaki,R.F.,et al, 1997
Response of the Pupil to Tropicamide is not a Reliable Test of Alzheimer Disease
Arch Neurol 54:155-159, FitzSimon,J.S.,et al, 1997
Risk of Alzheimer's Disease and Duration of NSAID Use
Neurol 48:626-632, Stewart,W.F.,et al, 1997
Telling Patients They Have Alzheimer's Disease
BMJ 314:321-322, 375-3761997., Rice,K.,et al, 1997
Collection and Normal Levels of the Amyloid Precursor Protein in Plasma
Ann Neurol 41:121-124, Whyte,S.,et al, 1997
Assessment of CSF Levels of Tau Protein in Mildly Demented Patients with Alzheimer's Disese
Neurol 48:632-635, Galasko,D.,et al, 1997
Criteria for Alzheimer's Disease and the Nosology of Dementia with Lewy Bodies
Neurol 48:126-132, Hansen,L.A.&Samuel,W., 1997
Comparison of Extrapyramidal Features in 31 Path Cases of Diffuse Lewy Body Disease & 34 Cases of Parkinson's
Neurol 48:376-380, Louis,E.D.,et al, 1997
Progression to Dementia in Patients with Isolated Memory Loss
Lancet 349:763-765, Bowen,J.,et al, 1997
A Prospective Study of Estrogen Replacement Therapy and the Risk of Developing Alzheimer's Disease
Neurol 48:1517-1521, Kawas,C.,et al, 1997
Measurement of Acetylcholinesterase by PET in the Brains of Healthy Controls & Pts with Alzheimer's Disease
Lancet 349:1805-1809, Iyo,M.,et al, 1997
The Effect of Different Diagnostic Criteria on the Prevalence of Dementia
NEJM 337:1667-1674, Erkinjuntti,T.,et al, 1997
Genetic Testing for Alzheimer Disease, Practical and Ethical Issues
Arch Neurol 54:1226-1229, Roses,A.D., 1997
Estrogen Replacement Therapy and Risk of Alzheimer Disease
Arch Int Med 156:2213-2217, Paganinni-Hill,A.&Henderson,V.W., 1996
Psychiatric Features in Diffuse Lewy Body Disease:A Clinicopath Study Using Alzheimer's & PD Groups
Neurol 47:1148-1152, Klatka,L.A.,et al, 1996
Dementia with Lewy Bodies:Reliability and Validity of Clinical and Pathologic Criteria
Neurol 47:1403-1409, Mega,M.S.,et al, 1996
Consensus Guidelines for Clin & Path Dx of Dementia with Lewy Bodies (DLB) :Report of DLB Intl Workshop
Neurol 47:1113-1114, 11241996., McKeith,I.G.,et al, 1996
Dementia and Driving:Screening, Assessment, and Advice
Lancet 348:1114, O'Neill,D., 1996
AIDS in the Elderly:New York City Vital Statistics
J Emerg Med 14:19-23, Gaeta,T.J.,et al, 1996
Noninvasive Perfusion MRI in Alzheimer's Disease:A Preliminary Report
Neurol 47:1339-1342, Sandson,T.A.,et al, 1996
Genetic Factors in Alzheimer's Disease:A Review of Recent Advances
Ann Neurol 40:829-840, Levy-Lahad,E.&Bird,T.D., 1996
Elevated Risk of Alzheimer's Disease Among Workers with Likely Electromagnetic Field Exposure
Neurol 47:1477-1481, Sobel,E.,et al, 1996
Electromagnetic Field Exposure May Cause Increased Production of Amyloid Beta & Eventually lead to Alzheimer's Disease
Neurol 47:1594-1600, Sobel,E.&Davanipour,Z., 1996
Diffuse Lewy Body Disease:Clinical Features in Nine Cases without Coexistent Alzheimer's Disease
JNNP 60:531-538, Hely,M.A.,et al, 1996
Preclinical Evidence of Alzheimer's Disease in Persons Homozygous for the e4Allele for Apolipoprotein E
NEJM 334:752-758, 7911996., Reiman,E.M.,et al, 1996
Alzheimer Disease and Nonfluent Progressive Aphasia
Arch Neurol 53:1072-1078, Greene,J.D.W.,et al, 1996
Incorrect Diagnosis of Alzheimer's Disease:A Clinicopathologic Study
Arch Neurol 53:35-42, Klatka,L.A.,et al, 1996
Subjective Memory Complaints May Announce Dementia
Neurol 46:121-125, Schmand,B.,et al, 1996
Dementia in a 58-year-old Woman
Lancet 347:236, Sellal,F.,et al, 1996
Assessment of Brain SPECT:Report of the Therapeutics and Technology Assessment Subcommittee of the AAN
Neurol 46:278-285, , 1996